Gemina Laboratories Stock Probability of Future OTC Stock Price Finishing Over 0.55
| GLABF Stock | USD 0.55 0.01 1.79% |
Gemina |
Gemina Laboratories Target Price Odds to finish over 0.55
The tendency of Gemina OTC Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 0.55 | 90 days | 0.55 | near 1 |
Based on a normal probability distribution, the odds of Gemina Laboratories to move above the current price in 90 days from now is near 1 (This Gemina Laboratories probability density function shows the probability of Gemina OTC Stock to fall within a particular range of prices over 90 days) .
Assuming the 90 days horizon the otc stock has the beta coefficient of 3.14 . This usually indicates as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Gemina Laboratories will likely underperform. Additionally Gemina Laboratories has an alpha of 0.6872, implying that it can generate a 0.69 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Gemina Laboratories Price Density |
| Price |
Predictive Modules for Gemina Laboratories
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Gemina Laboratories. Regardless of method or technology, however, to accurately forecast the otc stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the otc stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Gemina Laboratories Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Gemina Laboratories is not an exception. The market had few large corrections towards the Gemina Laboratories' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Gemina Laboratories, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Gemina Laboratories within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.69 | |
β | Beta against Dow Jones | 3.14 | |
σ | Overall volatility | 0.08 | |
Ir | Information ratio | 0.14 |
Gemina Laboratories Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Gemina Laboratories for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Gemina Laboratories can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Gemina Laboratories is way too risky over 90 days horizon | |
| Gemina Laboratories has some characteristics of a very speculative penny stock | |
| Gemina Laboratories appears to be risky and price may revert if volatility continues | |
| Gemina Laboratories has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (4.73 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Gemina Laboratories has accumulated about 2.95 M in cash with (3.87 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.05. | |
| Roughly 56.0% of the company shares are held by company insiders |
Gemina Laboratories Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Gemina OTC Stock often depends not only on the future outlook of the current and potential Gemina Laboratories' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Gemina Laboratories' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 55.6 M |
Gemina Laboratories Technical Analysis
Gemina Laboratories' future price can be derived by breaking down and analyzing its technical indicators over time. Gemina OTC Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Gemina Laboratories. In general, you should focus on analyzing Gemina OTC Stock price patterns and their correlations with different microeconomic environments and drivers.
Gemina Laboratories Predictive Forecast Models
Gemina Laboratories' time-series forecasting models is one of many Gemina Laboratories' otc stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Gemina Laboratories' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the otc stock market movement and maximize returns from investment trading.
Things to note about Gemina Laboratories
Checking the ongoing alerts about Gemina Laboratories for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Gemina Laboratories help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Gemina Laboratories is way too risky over 90 days horizon | |
| Gemina Laboratories has some characteristics of a very speculative penny stock | |
| Gemina Laboratories appears to be risky and price may revert if volatility continues | |
| Gemina Laboratories has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (4.73 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Gemina Laboratories has accumulated about 2.95 M in cash with (3.87 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.05. | |
| Roughly 56.0% of the company shares are held by company insiders |
Other Information on Investing in Gemina OTC Stock
Gemina Laboratories financial ratios help investors to determine whether Gemina OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Gemina with respect to the benefits of owning Gemina Laboratories security.